|View printer-friendly version|
|OpGen Awarded CDC Contract to Develop Clinical Support Tools for Antimicrobial Stewardship and Infection Control|
“OpGen looks forward to working with the CDC to help address this urgent global need,” stated
OpGen’s teaming partner Teqqa will provide its cloud- and mobile-based software platform, which integrates electronic patient data and local empiric treatment guidelines to support antimicrobial stewardship. The Teqqa platform is a state-of-the-art mobile AMS solution that is commercially available and in use in major medical centers. The mobile platform will be extended to quickly identify patients requiring infection control precautions, assist with the implementation of appropriate precautions, and assist with the collection and tracking of indicators for monitoring implementation of infection control precautions. The software will be translated to Spanish and will support WHONET data integration.
“Connection to WHONET is a critical enabling component to this initiative,” continued Mr. Jones. “WHONET is an information system developed to support the World Health Organization’s goal of global surveillance of bacterial resistance to antimicrobial agents. WHONET analyzes the data of over 4,000 laboratories worldwide and is used in more than 120 countries.”
“Dr. Villegas and the UEB team will guide the customization of the AMS software for the needs of low- and middle-income countries. They also will work with
About the CDC BAA Awards
According to the CDC, it has awarded more than
These awards, made through a broad agency announcement (BAA), are part of the CDC’s Antibiotic Resistance Solutions Initiative and are intended to grow the agency’s innovative approaches to combat antibiotic resistance. In fiscal years 2016 and 2017, the Antibiotic Resistance Solutions Initiative awarded more than
OpGen® is a registered trademark of OpGen, Inc.